# CORRESP — Jaguar Health, Inc.  (JAGX)  (CIK 0001585608)

> <strong>Jaguar Health, Inc.  (JAGX)  (CIK 0001585608) → SEC staff</strong> · filed 2025-11-24 · ticker JAGX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-25-293735
- **Form:** CORRESP
- **Filer:** Jaguar Health, Inc.  (JAGX)  (CIK 0001585608)
- **CIK:** 0001585608
- **Ticker:** JAGX
- **Filed:** 2025-11-24
- **SIC industry:** 2834
- **HQ:** San Francisco, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1585608/000119312525293735/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1585608&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Jaguar Health, Inc.  (JAGX)  (CIK 0001585608) (CIK 0001585608), filed 2025-11-24, accession 0001193125-25-293735. Retrieved via MORVS 2026-11-14 from https://api.morvs.ai/comment-letter/0001193125-25-293735.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*